Related Experiment Video

Updated: Aug 13, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Inhibition of nitric oxide synthesis does not improve interleukin-2-mediated antitumor effects in vivo

G H Leder1, M Oppenheim, M Rosenstein

  • 1Department of Surgery, University of Pittsburgh School of Medicine, USA.

European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes
|January 1, 1996
PubMed

Insights

Inhibiting nitric oxide (NO) with aminoguanidine (AG) did not enhance interleukin-2 (IL-2) immunotherapy efficacy against lung metastases in mice. NO inhibition also failed to reduce IL-2-induced capillary leak, a major side effect.

Area of Science:

  • Immunology
  • Pharmacology
  • Cancer Research

Background:

  • Nitric oxide (NO) inhibits cytotoxic lymphocyte (CTL) activity in vitro.
  • Interleukin-2 (IL-2) immunotherapy stimulates CTLs but causes side effects like hypotension.
  • NO synthase (NOS) inhibitors can prevent NO production.

Purpose of the Study:

  • To determine if inhibiting IL-2-induced NOS enhances CTL efficacy in vivo.
  • To investigate if NO contributes to IL-2-associated capillary leak.

Main Methods:

  • Mice with lung metastases were treated with IL-2, a NOS inhibitor (aminoguanidine, AG), or both.
  • Lung metastases, NO production, and pulmonary edema were assessed.

Main Results:

  • Combination therapy (IL-2 + AG) showed no improvement in reducing lung metastases compared to IL-2 alone.
  • AG normalized NO production but did not affect IL-2-induced pulmonary edema.
  • NO inhibition did not improve antitumor effects or reduce capillary leak.

Conclusions:

  • Inhibition of IL-2-induced NO does not enhance the antitumor efficacy of IL-2-stimulated CTLs in vivo.
  • NO does not appear to be the primary mediator of IL-2-associated capillary leak syndrome.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...